Just one day after filing a prospectus with the SEC for a registered underwritten public offering, Momenta Pharmaceuticals Inc. has priced the offering of 4 million shares of its common stock (NASDAQ:MNTA) at $14.35 per share. The proceeds, before expenses, to Momenta will be approximately $57.4 million.